Associations between eGFR and albuminuria with right ventricular measures : the MESA-Right Ventricle study
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA..
Background: Chronic kidney disease (CKD) is associated with an increased risk of pulmonary hypertension, which may lead to right ventricular (RV) pressure overload and RV dysfunction. However, the presence of subclinical changes in RV structure or function in early CKD and the influence of these changes on mortality are not well studied. We hypothesized that early CKD, as indicated by elevated albuminuria or mild reductions in estimated glomerular filtration rate (eGFR), is associated with greater RV dilation and RV mass.
Methods: We included 4063 participants (age 45-84 years) without baseline clinical cardiovascular disease from the Multi-Ethnic Study of Atherosclerosis. The associations of baseline creatinine-cystatin C-based eGFR and albuminuria with cardiac magnetic resonance-derived RV measures (2000-02) were examined cross-sectionally with linear regression models. Cox regression models were used to examine whether RV parameters modified the associations of eGFR and albuminuria with all-cause mortality.
Results: Participants with reductions in eGFR primarily within the 60-89 mL/min/1.73 m2 category had smaller RV end-diastolic and end-systolic volumes and stroke volume (all adjusted P-trends <.001) than those with eGFR ≥90 mL/min/1.73 m2, an association that was predominantly seen in participants with albuminuria below 30 mg/g creatinine. Albuminuria was more strongly associated with death among those with lower RV volumes (P-values for interaction <.03).
Conclusions: Among community-dwelling adults, reductions in eGFR primarily within the normal range were associated with smaller RV volumes and the association of albuminuria with worse survival was stronger among those with smaller RV volumes. Further studies are needed to elucidate the underlying mechanistic pathways that link kidney measures and RV morphology.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Clinical kidney journal - 16(2023), 9 vom: 15. Sept., Seite 1508-1520 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Husain-Syed, Faeq [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cardiac magnetic resonance |
|---|
| Anmerkungen: |
Date Revised 24.10.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/ckj/sfad096 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361622856 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361622856 | ||
| 003 | DE-627 | ||
| 005 | 20231226085531.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ckj/sfad096 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1205.xml |
| 035 | |a (DE-627)NLM361622856 | ||
| 035 | |a (NLM)37664568 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Husain-Syed, Faeq |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Associations between eGFR and albuminuria with right ventricular measures |b the MESA-Right Ventricle study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.10.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. | ||
| 520 | |a Background: Chronic kidney disease (CKD) is associated with an increased risk of pulmonary hypertension, which may lead to right ventricular (RV) pressure overload and RV dysfunction. However, the presence of subclinical changes in RV structure or function in early CKD and the influence of these changes on mortality are not well studied. We hypothesized that early CKD, as indicated by elevated albuminuria or mild reductions in estimated glomerular filtration rate (eGFR), is associated with greater RV dilation and RV mass | ||
| 520 | |a Methods: We included 4063 participants (age 45-84 years) without baseline clinical cardiovascular disease from the Multi-Ethnic Study of Atherosclerosis. The associations of baseline creatinine-cystatin C-based eGFR and albuminuria with cardiac magnetic resonance-derived RV measures (2000-02) were examined cross-sectionally with linear regression models. Cox regression models were used to examine whether RV parameters modified the associations of eGFR and albuminuria with all-cause mortality | ||
| 520 | |a Results: Participants with reductions in eGFR primarily within the 60-89 mL/min/1.73 m2 category had smaller RV end-diastolic and end-systolic volumes and stroke volume (all adjusted P-trends <.001) than those with eGFR ≥90 mL/min/1.73 m2, an association that was predominantly seen in participants with albuminuria below 30 mg/g creatinine. Albuminuria was more strongly associated with death among those with lower RV volumes (P-values for interaction <.03) | ||
| 520 | |a Conclusions: Among community-dwelling adults, reductions in eGFR primarily within the normal range were associated with smaller RV volumes and the association of albuminuria with worse survival was stronger among those with smaller RV volumes. Further studies are needed to elucidate the underlying mechanistic pathways that link kidney measures and RV morphology | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cardiac magnetic resonance | |
| 650 | 4 | |a cardiorenal syndromes | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a kidney function | |
| 650 | 4 | |a pulmonary hypertension | |
| 700 | 1 | |a DiFrancesco, Matthew F |e verfasserin |4 aut | |
| 700 | 1 | |a Deo, Rajat |e verfasserin |4 aut | |
| 700 | 1 | |a Barr, R Graham |e verfasserin |4 aut | |
| 700 | 1 | |a Scialla, Julia J |e verfasserin |4 aut | |
| 700 | 1 | |a Bluemke, David A |e verfasserin |4 aut | |
| 700 | 1 | |a Kronmal, Richard A |e verfasserin |4 aut | |
| 700 | 1 | |a Lima, Joao A C |e verfasserin |4 aut | |
| 700 | 1 | |a Praestgaard, Amy |e verfasserin |4 aut | |
| 700 | 1 | |a Tracy, Russell P |e verfasserin |4 aut | |
| 700 | 1 | |a Shlipak, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Kawut, Steven M |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, John S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical kidney journal |d 2012 |g 16(2023), 9 vom: 15. Sept., Seite 1508-1520 |w (DE-627)NLM219739579 |x 2048-8505 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:9 |g day:15 |g month:09 |g pages:1508-1520 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ckj/sfad096 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 9 |b 15 |c 09 |h 1508-1520 | ||